Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
about
Management of EGFR-inhibitor associated rash: a retrospective study in 49 patientsAcute and Chronic Cutaneous Reactions to Ionizing Radiation TherapySymptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: A review of the literature and areas for future researchHyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study.Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocolsProcedure, applications, and outcomes of autologous fat grafting.Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach.Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancerClinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma.Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review.Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis.Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients.Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management.Recurrent oral cancer: current and emerging therapeutic approaches.Reducing radiation in chronic total occlusion percutaneous coronary interventions.Cetuximab: its unique place in head and neck cancer treatmentA review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis.A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patientsTreatment of recurrent metastatic head and neck cancer: focus on cetuximab.Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel.Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology.Treatment of head and neck cancers: issues for clinical pharmacists.Emerging molecular targeted therapies in the treatment of head and neck cancer.Cetuximab in the treatment of squamous cell carcinoma of the head and neck.Contemporary clinical management of oral squamous cell carcinoma.Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors.Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.Skin toxicity of targeted cancer agents: mechanisms and intervention.Targeted therapy in nonmelanoma skin cancers.Outcomes toolbox for head and neck cancer research.Hazards and risks in oncology: radiation oncology.Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development.Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas.Radiation dermatitis: an overview.Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck.Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies.The potential benefits of using aloe vera in stoma patient skin care.Grade 4 radiation dermatitis presenting with full-thickness ulcerations of the groin after radiation therapy for anal squamous cell carcinoma (SCC): An example of the "bolus effect" of radiation therapy.
P2860
Q21195817-57DD301A-A455-4BB0-93F4-893FA64AA835Q26744148-ADFA7E2C-8BFB-4DDF-81C9-3916149D842DQ26747701-65297E1F-AA9D-47AF-915F-B4E94B2ED6C2Q30313175-D38FDD76-6705-4D66-A9E6-4FEE7C027FD0Q30355452-51F86E2A-9637-40F5-86BF-E28680298E84Q33854196-EDFEADC1-E7AE-4381-BE23-540CDE4B589AQ34084382-F1816926-22F8-48A4-9686-AEA7964BF069Q34596781-60A062A1-B039-4342-A3F7-5A4DF694D3BFQ34940071-5F3ED7B5-0FF8-4873-9D06-4E82F3EF980CQ35584416-29279C03-54BD-4C88-8444-9C6BE3419772Q35905979-B357941D-9ADE-4790-AF17-839E396B2535Q35913241-A98796EE-ED6C-4BF3-8E3B-6F2E59B2D347Q36026706-8BCE8D9E-1D12-404C-A895-DD3C002AE86FQ36078657-0B869FD4-1695-48F3-AF0B-F6CC5DC4C331Q36246406-86CE5244-62BC-4B7E-BB81-844F5AF0B9C1Q36283038-6B3A152C-CE8F-4A5E-8A29-54D24B6304E7Q36728662-F9C59856-BA0A-4D54-906C-9AE9F13D13D2Q36880604-032E146C-1A8F-45FF-9305-1F793156039FQ36951089-A9197A5C-7319-4282-8633-3054BD213DF2Q37025511-9777C187-5DC9-4922-BE79-04600D8A2A34Q37218978-6E7A7701-F684-4043-83FF-B785C3326C11Q37390753-057148E0-FC9A-4F71-99A7-6D76C89BEB9BQ37442683-A7150D98-3D30-4933-916F-8A35139C04D7Q37461437-52CC7A78-207D-45BD-9057-79B952C2F703Q37515438-9C594200-7ADD-47CE-8BF2-8023319080C1Q37866779-D02B17A5-C545-4AA4-BFBD-5893D8590065Q37903906-56B572CD-3894-4BB2-AF3E-5A25F1C89FA5Q37987802-0102D656-BE07-41D1-9BB6-258FF8F13171Q38005946-7B99CD97-1796-465D-97C1-BF3FCCCEB06FQ38125504-C66113B3-2617-431F-B8CC-3E67B0AC8A83Q38161358-3099AD7C-DAB5-450F-B5B2-EF169DB0C195Q38169571-5190B075-2469-472F-94BB-033F1AB1A25BQ38176904-4B344A24-E2A6-4EE1-9716-DDC17BC43DFDQ38726934-CDF1F8BF-A75D-4BAD-92D8-15383385FACFQ38807206-E1BD94DA-230A-4FDF-A240-FAFEE73B34F2Q38920186-E1F026FA-6D0A-4774-9CA8-8F0DFB7044B3Q38936131-BDA5A74C-732E-4EB0-AAA6-41860935D176Q39110385-050BCA00-A4FC-4948-8B39-F76493201C16Q39193011-A65BE8CE-DA0D-4604-8314-1FC5E1883AD1Q39558853-FC926BAC-CCA8-41C8-BCCF-72B5F6E051AE
P2860
Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Consensus guidelines for the m ...... carcinoma of the head and neck
@ast
Consensus guidelines for the m ...... carcinoma of the head and neck
@en
Consensus guidelines for the m ...... carcinoma of the head and neck
@nl
type
label
Consensus guidelines for the m ...... carcinoma of the head and neck
@ast
Consensus guidelines for the m ...... carcinoma of the head and neck
@en
Consensus guidelines for the m ...... carcinoma of the head and neck
@nl
prefLabel
Consensus guidelines for the m ...... carcinoma of the head and neck
@ast
Consensus guidelines for the m ...... carcinoma of the head and neck
@en
Consensus guidelines for the m ...... carcinoma of the head and neck
@nl
P2093
P3181
P356
P1433
P1476
Consensus guidelines for the m ...... carcinoma of the head and neck
@en
P2093
J B Vermorken
R-J Bensadoun
P3181
P356
10.1093/ANNONC/MDM400
P407
P577
2008-01-01T00:00:00Z